Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation

Abstract Pancreatic beta cells undergo compensatory proliferation in the early phase of type 2 diabetes. While pathways such as FoxM1 are involved in regulating compensatory beta cell proliferation, given the lack of therapeutics effectively targeting beta cell proliferation, other targetable pathwa...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian Ma, Bowen Xing, Yan Cao, Xin He, Kate E Bennett, Chao Tong, Chiying An, Taylor Hojnacki, Zijie Feng, Sunbin Deng, Sunbin Ling, Gengchen Xie, Yuan Wu, Yue Ren, Ming Yu, Bryson W Katona, Hongzhe Li, Ali Naji, Xianxin Hua
Format: Article
Language:English
Published: Springer Nature 2021-04-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202013524
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331923794526208
author Jian Ma
Bowen Xing
Yan Cao
Xin He
Kate E Bennett
Chao Tong
Chiying An
Taylor Hojnacki
Zijie Feng
Sunbin Deng
Sunbin Ling
Gengchen Xie
Yuan Wu
Yue Ren
Ming Yu
Bryson W Katona
Hongzhe Li
Ali Naji
Xianxin Hua
author_facet Jian Ma
Bowen Xing
Yan Cao
Xin He
Kate E Bennett
Chao Tong
Chiying An
Taylor Hojnacki
Zijie Feng
Sunbin Deng
Sunbin Ling
Gengchen Xie
Yuan Wu
Yue Ren
Ming Yu
Bryson W Katona
Hongzhe Li
Ali Naji
Xianxin Hua
author_sort Jian Ma
collection DOAJ
description Abstract Pancreatic beta cells undergo compensatory proliferation in the early phase of type 2 diabetes. While pathways such as FoxM1 are involved in regulating compensatory beta cell proliferation, given the lack of therapeutics effectively targeting beta cell proliferation, other targetable pathways need to be identified. Herein, we show that Pbk, a serine/threonine protein kinase, is essential for high fat diet (HFD)‐induced beta cell proliferation in vivo using a Pbk kinase deficiency knock‐in mouse model. Mechanistically, JunD recruits menin and HDAC3 complex to the Pbk promoter to reduce histone H3 acetylation, leading to epigenetic repression of Pbk expression. Moreover, menin inhibitor (MI) disrupts the menin–JunD interaction and augments Pbk transcription. Importantly, MI administration increases beta cell proliferation, ameliorating hyperglycemia, and impaired glucose tolerance (IGT) in HFD‐induced diabetic mice. Notably, Pbk is required for the MI‐induced beta cell proliferation and improvement of IGT. Together, these results demonstrate the repressive role of the menin/JunD/Pbk axis in regulating HFD‐induced compensatory beta cell proliferation and pharmacologically regulating this axis may serve as a novel strategy for type 2 diabetes therapy.
format Article
id doaj-art-d764a053a59a49c5a1e44e7b4becb24f
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2021-04-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-d764a053a59a49c5a1e44e7b4becb24f2025-08-20T03:46:21ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842021-04-0113512210.15252/emmm.202013524Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferationJian Ma0Bowen Xing1Yan Cao2Xin He3Kate E Bennett4Chao Tong5Chiying An6Taylor Hojnacki7Zijie Feng8Sunbin Deng9Sunbin Ling10Gengchen Xie11Yuan Wu12Yue Ren13Ming Yu14Bryson W Katona15Hongzhe Li16Ali Naji17Xianxin Hua18Department of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDivision of Gastroenterology, University of Pennsylvania Perelman School of MedicineDepartment of Biology, University of PennsylvaniaDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Chemistry, University of PennsylvaniaDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of MedicineInstitute for Diabetes, Obesity, and Metabolism, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of MedicineInstitute for Diabetes, Obesity, and Metabolism, University of Pennsylvania Perelman School of MedicineDepartment of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of MedicineAbstract Pancreatic beta cells undergo compensatory proliferation in the early phase of type 2 diabetes. While pathways such as FoxM1 are involved in regulating compensatory beta cell proliferation, given the lack of therapeutics effectively targeting beta cell proliferation, other targetable pathways need to be identified. Herein, we show that Pbk, a serine/threonine protein kinase, is essential for high fat diet (HFD)‐induced beta cell proliferation in vivo using a Pbk kinase deficiency knock‐in mouse model. Mechanistically, JunD recruits menin and HDAC3 complex to the Pbk promoter to reduce histone H3 acetylation, leading to epigenetic repression of Pbk expression. Moreover, menin inhibitor (MI) disrupts the menin–JunD interaction and augments Pbk transcription. Importantly, MI administration increases beta cell proliferation, ameliorating hyperglycemia, and impaired glucose tolerance (IGT) in HFD‐induced diabetic mice. Notably, Pbk is required for the MI‐induced beta cell proliferation and improvement of IGT. Together, these results demonstrate the repressive role of the menin/JunD/Pbk axis in regulating HFD‐induced compensatory beta cell proliferation and pharmacologically regulating this axis may serve as a novel strategy for type 2 diabetes therapy.https://doi.org/10.15252/emmm.202013524beta cellcompensatory proliferationdiabetesmeninPbk
spellingShingle Jian Ma
Bowen Xing
Yan Cao
Xin He
Kate E Bennett
Chao Tong
Chiying An
Taylor Hojnacki
Zijie Feng
Sunbin Deng
Sunbin Ling
Gengchen Xie
Yuan Wu
Yue Ren
Ming Yu
Bryson W Katona
Hongzhe Li
Ali Naji
Xianxin Hua
Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
EMBO Molecular Medicine
beta cell
compensatory proliferation
diabetes
menin
Pbk
title Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
title_full Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
title_fullStr Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
title_full_unstemmed Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
title_short Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
title_sort menin regulated pbk controls high fat diet induced compensatory beta cell proliferation
topic beta cell
compensatory proliferation
diabetes
menin
Pbk
url https://doi.org/10.15252/emmm.202013524
work_keys_str_mv AT jianma meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT bowenxing meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT yancao meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT xinhe meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT kateebennett meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT chaotong meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT chiyingan meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT taylorhojnacki meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT zijiefeng meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT sunbindeng meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT sunbinling meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT gengchenxie meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT yuanwu meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT yueren meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT mingyu meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT brysonwkatona meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT hongzheli meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT alinaji meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation
AT xianxinhua meninregulatedpbkcontrolshighfatdietinducedcompensatorybetacellproliferation